JP2016506905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506905A5 JP2016506905A5 JP2015552077A JP2015552077A JP2016506905A5 JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5 JP 2015552077 A JP2015552077 A JP 2015552077A JP 2015552077 A JP2015552077 A JP 2015552077A JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5
- Authority
- JP
- Japan
- Prior art keywords
- azide
- saccharide
- group
- spacer
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1300707.5 | 2013-01-15 | ||
| GBGB1300707.5A GB201300707D0 (en) | 2013-01-15 | 2013-01-15 | Compounds and processes |
| PCT/EP2014/050483 WO2014111344A1 (en) | 2013-01-15 | 2014-01-13 | Cycloalkyne derivatized saccharides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018246761A Division JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016506905A JP2016506905A (ja) | 2016-03-07 |
| JP2016506905A5 true JP2016506905A5 (enExample) | 2017-02-09 |
| JP6719209B2 JP6719209B2 (ja) | 2020-07-08 |
Family
ID=47758014
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552077A Active JP6719209B2 (ja) | 2013-01-15 | 2014-01-13 | シクロアルキン誘導体化糖類 |
| JP2018246761A Withdrawn JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
| JP2020050828A Active JP7036854B2 (ja) | 2013-01-15 | 2020-03-23 | シクロアルキン誘導体化糖類 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018246761A Withdrawn JP2019073528A (ja) | 2013-01-15 | 2018-12-28 | シクロアルキン誘導体化糖類 |
| JP2020050828A Active JP7036854B2 (ja) | 2013-01-15 | 2020-03-23 | シクロアルキン誘導体化糖類 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11135300B2 (enExample) |
| EP (1) | EP2945641B1 (enExample) |
| JP (3) | JP6719209B2 (enExample) |
| CN (1) | CN105377282B (enExample) |
| BR (1) | BR112015016817B1 (enExample) |
| CA (1) | CA2897348C (enExample) |
| CY (1) | CY1122822T1 (enExample) |
| DK (1) | DK2945641T3 (enExample) |
| ES (1) | ES2774729T3 (enExample) |
| GB (1) | GB201300707D0 (enExample) |
| HR (1) | HRP20200351T1 (enExample) |
| LT (1) | LT2945641T (enExample) |
| PL (1) | PL2945641T3 (enExample) |
| PT (1) | PT2945641T (enExample) |
| SI (1) | SI2945641T1 (enExample) |
| WO (1) | WO2014111344A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
| CN108697741B (zh) * | 2016-03-04 | 2023-04-14 | 悠绿那股份有限公司 | 抗病毒剂及抗病毒用食品 |
| EP4588521A3 (en) | 2016-12-30 | 2025-10-22 | Vaxcyte, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| JP7295571B2 (ja) * | 2018-02-05 | 2023-06-21 | 国立大学法人 宮崎大学 | 細胞標識剤及び細胞標識キット |
| EP3808783A4 (en) | 2018-06-14 | 2022-03-16 | Mochida Pharmaceutical Co., Ltd. | Novel crosslinked alginic acid |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| KR20230052958A (ko) | 2020-08-19 | 2023-04-20 | 박사이트, 인코포레이티드 | 운반-단백질 폴리삭카라이드 접합 방법 |
| KR20230175284A (ko) * | 2021-05-28 | 2023-12-29 | 화이자 인코포레이티드 | 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도 |
| JP2024075506A (ja) * | 2022-11-22 | 2024-06-03 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1490409E (pt) | 2002-03-26 | 2009-04-03 | Novartis Vaccines & Diagnostic | Sacáridos modificados possuindo uma estabilidade melhorada em água |
| MX2007005202A (es) * | 2004-11-01 | 2007-07-09 | Brigham & Womens Hospital | Polisacaridos de estreptococo modificados y usos de los mismos. |
| GB0502095D0 (en) * | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| CN101925366B (zh) * | 2007-11-21 | 2015-02-04 | 乔治亚大学研究基金公司 | 炔烃以及炔烃与1,3-偶极-官能化合物反应的方法 |
| ITVI20090234A1 (it) * | 2009-09-25 | 2011-03-26 | Termotecniche Fraccaro S R L Off | Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo |
| EP2515914A4 (en) | 2009-12-23 | 2013-09-11 | Scripps Research Inst | BIOCONJUGATION OF TYROSINE BY EYE REACTIONS IN AQUEOUS MEDIA |
| US8859629B2 (en) * | 2010-04-27 | 2014-10-14 | Synaffix B.V. | Fused cyclooctyne compounds and their use in metal-free click reactions |
| WO2012017701A1 (ja) * | 2010-08-05 | 2012-02-09 | 株式会社ミュージックゲート | いびき防止マスク |
| GB201101665D0 (en) * | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| US9315468B2 (en) | 2010-09-27 | 2016-04-19 | University Of Georgia Research Foundation, Inc. | Methods including latent 1,3-dipole-functional compounds and materials prepared thereby |
| US20120208722A1 (en) * | 2010-10-19 | 2012-08-16 | Richard Dluhy | Surface enhanced raman spectroscopy platforms and methods |
| WO2012177701A2 (en) * | 2011-06-20 | 2012-12-27 | Radiomedix Inc. | Compositions, methods of synthesis and use of carbohydrate targeted agents |
| HK1200190A1 (en) * | 2011-12-01 | 2015-07-31 | 安吉奥开米公司 | Targeted enzyme compounds and uses thereof |
| GB201300707D0 (en) * | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
-
2013
- 2013-01-15 GB GBGB1300707.5A patent/GB201300707D0/en not_active Ceased
-
2014
- 2014-01-13 WO PCT/EP2014/050483 patent/WO2014111344A1/en not_active Ceased
- 2014-01-13 CN CN201480012960.8A patent/CN105377282B/zh active Active
- 2014-01-13 LT LTEP14700602.7T patent/LT2945641T/lt unknown
- 2014-01-13 CA CA2897348A patent/CA2897348C/en active Active
- 2014-01-13 SI SI201431496T patent/SI2945641T1/sl unknown
- 2014-01-13 PT PT147006027T patent/PT2945641T/pt unknown
- 2014-01-13 PL PL14700602T patent/PL2945641T3/pl unknown
- 2014-01-13 DK DK14700602.7T patent/DK2945641T3/da active
- 2014-01-13 BR BR112015016817-5A patent/BR112015016817B1/pt active IP Right Grant
- 2014-01-13 JP JP2015552077A patent/JP6719209B2/ja active Active
- 2014-01-13 US US14/760,916 patent/US11135300B2/en active Active
- 2014-01-13 EP EP14700602.7A patent/EP2945641B1/en active Active
- 2014-01-13 HR HRP20200351TT patent/HRP20200351T1/hr unknown
- 2014-01-13 ES ES14700602T patent/ES2774729T3/es active Active
-
2018
- 2018-12-28 JP JP2018246761A patent/JP2019073528A/ja not_active Withdrawn
-
2020
- 2020-03-13 CY CY20201100223T patent/CY1122822T1/el unknown
- 2020-03-23 JP JP2020050828A patent/JP7036854B2/ja active Active
-
2021
- 2021-05-14 US US17/320,482 patent/US12409231B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506905A5 (enExample) | ||
| WO2008083174A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| HRP20200351T1 (hr) | Cikloalkinski derivati saharida | |
| WO2018098269A3 (en) | Peptide-containing linkers for antibody-drug conjugates | |
| WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
| WO2009082819A8 (en) | Novel lupane derivatives | |
| GB201101665D0 (en) | Immunogenic compositions | |
| JP2012528865A5 (enExample) | ||
| DE60323756D1 (de) | Pharmazeutisch aktive oligosaccharid-conjugate | |
| WO2007062107A3 (en) | Immunostimulatory oligoribonucleotides | |
| CL2008003153A1 (es) | Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras. | |
| EP3912642A8 (en) | Modified antibody, antibody-conjugate and process for the preparation thereof | |
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| TW200700093A (en) | Pharmaceutical composition for the treatment of cancer | |
| WO2009088838A3 (en) | Triarylmethane analogs and their use in treating cancers | |
| JP2017505777A5 (enExample) | ||
| WO2015066053A3 (en) | Targeted therapeutics | |
| JP2015501329A5 (enExample) | ||
| Tabakmakher et al. | Normonanchocidins A, B and D, new pentacyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchra | |
| US20230382945A1 (en) | Therapeutic agents and methods | |
| RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| WO2015009731A3 (en) | Azacyclic constrained analogs of fty720 | |
| WO2016003158A3 (ko) | DX2 단백질과 p14/ARF 단백질 간의 결합을 억제하는 신규 화합물 및 상기 화합물을 유효성분으로 함유하는 암질환 치료 또는 예방용 약학조성물 |